Vizimpro
Product Images NDC 63539-197

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Vizimpro (NDC 63539-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vizimpro 01)

Chemical structure diagram of the active ingredient in Vizimpro, illustrating its molecular framework with fluorine, chlorine, methoxy, and piperidinyl groups, along with a water molecule indicating it is a hydrate form.*

FDA Label Image

Figure 1 (Vizimpro 02)

A Kaplan-Meier curve comparing the probability of progression-free survival over months for Vizimpro versus Gefitinib. The x-axis represents progression-free survival in months, while the y-axis shows the probability of progression-free survival. Patient numbers at risk for each treatment group are listed below the graph at various time points. Vizimpro shows higher progression-free survival probability compared to Gefitinib.*

FDA Label Image

Figure 2 (Vizimpro 03)

A Kaplan-Meier survival curve comparing overall survival probabilities over months for Vizimpro versus Gefitinib. The chart includes survival probability on the y-axis and time in months on the x-axis, with lines representing each treatment group and a table below indicating numbers of patients at risk at different time points. The graph visually displays survival trends for both drugs across a 48-month period.*

FDA Label Image

Logo (Vizimpro 04)

FDA Label Image

Logo (Vizimpro 05)

FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

Label for Vizimpro 15 mg tablets containing dacotinib, distributed by U.S. Pharmaceuticals. The label indicates a professional sample, not for sale, with a package size of 90 tablets. It includes storage instructions and notes the product is made in Ireland and distributed by Pfizer Inc., NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.